Liver transplantation for malignancies—including metastatic colorectal cancer neuroendocrine tumors—is an emerging area of interest in oncology and transplant medicine. Speakers delve into the latest advancements, clinical outcomes, and patient selection criteria for this innovative approach. Experts share insights into the current evidence, ongoing clinical trials, and the multidisciplinary strategies needed to optimize patient outcomes. The session also includes an in-depth discussion on the feasibility, ethical considerations, and future directions of transplant oncology.
Review the underlying rationale and latest clinical trial data and outcomes supporting liver transplantation as a therapeutic option for patients with metastatic cancer to the liver and neuroendocrine tumor.
Describe patient selection criteria and multidisciplinary approaches for optimizing transplant success in patients with metastatic cancer to the liver and neuroendocrine tumor.
Identify ethical and logistical challenges related to resource allocation and long-term outcomes in liver transplantation for metastatic colorectal cancer and neuroendocrine tumor.